144 completed, 107 recruiting, 75 active not recruiting, 58 unknown. 128 Phase 2, 118 Not applicable, 80 Phase 1, 25 Phase 3, 11 Early Phase 1.
Follow X-Rays: new trials by email Literature Review of X-Rays trials Research Report on X-Rays
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| ²¹¹At-OKT10-B10 and Fludarabine Alone or in Combination With Cyclophosphamide and Low-Dose TBI Before Donor Stem Cell Transplant for the Treatment of Newly Diagnosed, Recurrent, or Refractory High-Risk Multiple Myeloma Allogeneic Hematopoietic Stem Cell Transplantation, Astatine At 211 Anti-CD38 Monoclonal Antibody OKT10-B10, Cyclophosphamide - Multiple Myeloma, Recurrent Multiple Myeloma | Phase 1 | Withdrawn | Fred Hutchinson Cancer Center | 2027-06-01 | 2026-09-11 | |
| Testing the Combination of Anti-Cancer Drugs, Selumetinib and DS-8201a (Trastuzumab Deruxtecan), for Advanced Pancreatic Ductal Adenocarcinoma Biospecimen Collection, Diagnostic Imaging Testing, Echocardiography Test - Advanced Pancreatic Ductal Adenocarcinoma, Metastatic Pancreatic Ductal Adenocarcinoma | Phase 1 / Phase 2 | Recruiting | National Cancer Institute (NCI) | 31 | 2027-06-01 | 2026-10-22 |
| Testing the Combination of Anti-Cancer Drugs, Botensilimab (AGEN1181) and Balstilimab (AGEN2034), After Standard Treatment for Colorectal Cancer, Combat Trial Balstilimab, Biopsy Procedure, Biospecimen Collection - Colorectal Adenocarcinoma, Stage II Colorectal Cancer AJCC v8 | Phase 2 | Recruiting | National Cancer Institute (NCI) | 20 | 2027-05-25 | 2026-09-29 |
| A Study on How to Safely Guide Surgery for Melanoma and Similar Skin Tumors in Children Using Pathology and Genetic Information Biospecimen Collection, Chest Radiography, Computed Tomography - Clinical Stage 0 Cutaneous Melanoma AJCC v8, Clinical Stage I Cutaneous Melanoma AJCC v8 | Phase 2 | Recruiting | Children's Oncology Group | 51 | 2027-05-15 | 2026-09-24 |
| Enfortumab Vedotin for the Treatment of Unresectable or Metastatic Radioiodine Refractory Differentiated Thyroid Cancer, Anaplastic Thyroid Cancer, Medullary Thyroid Cancer, or NUT Carcinoma Biopsy Procedure, Biospecimen Collection, Computed Tomography - Metastatic Differentiated Thyroid Gland Carcinoma, Metastatic NUT Carcinoma | Phase 2 | Not yet recruiting | Northwestern University | 56 | 2027-05-05 | 2026-10-07 |
| Genetically Engineered Cells (BAFFR-CAR T Cells) for the Treatment of Relapsed or Refractory B-cell Acute Lymphoblastic Leukemia and B-cell Lymphoblastic Lymphoma Autologous BAFFR-targeting CAR T Cells, Biospecimen Collection, Bone Marrow Aspiration - Recurrent B Acute Lymphoblastic Leukemia, Recurrent B Lymphoblastic Lymphoma | Phase 1 | Not yet recruiting | City of Hope Medical Center | 16 | 2027-04-17 | 2026-08-11 |
| Testing the Addition of an Anti-Cancer Drug, Daraxonrasib, for Relapsed or Refractory Solid Tumors With RAS Mutations Biospecimen Collection, Bone Marrow Aspiration, Bone Marrow Biopsy - Recurrent Childhood Malignant Solid Neoplasm, Recurrent Childhood Neuroblastoma | Phase 1 / Phase 2 | Not yet recruiting | Children's Oncology Group | 77 | 2027-04-09 | 2026-09-15 |
| Autologous Tumor Infiltrating Lymphocytes With Interleukin-2 for the Treatment of Locally Advanced, Recurrent or Metastatic Gastrointestinal Stromal Tumors Aldesleukin, Biospecimen Collection, Chest Radiography - Locally Advanced Gastrointestinal Stromal Tumor, Metastatic Gastrointestinal Stromal Tumor | Phase 2 | Not yet recruiting | Joal Beane | 59 | 2027-02-15 | 2026-10-13 |
| A Bowel Management Program (Retrograde Rectal Enema) for the Treatment of Low Anterior Resection Syndrome in Rectal Cancer Patients Dietary Fiber, Enema Administration, Loperamide Hydrochloride - Low Anterior Resection Syndrome, Rectal Carcinoma | Not applicable | Recruiting | Ohio State University Comprehensive Cancer Center | 80 | 2027-02-15 | 2026-10-06 |
| Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial) Allogeneic Hematopoietic Stem Cell Transplantation, Biospecimen Collection, Bone Marrow Biopsy - Acute Myeloid Leukemia | Phase 2 | Not yet recruiting | National Cancer Institute (NCI) | 244 | 2027-01-15 | 2026-10-20 |
| Quantifying Multi-step Avoidance in Anxiety Behavioral Tasks with imaging - Anxiety, Anxiety Disorders | Not applicable | Not yet recruiting | Emory University | 163 | 2027-01-01 | 2026-10-05 |
| Utilize Imaging to Assess Changes in Hepatocellular Carcinoma Perfusion as Potentiated by Intra-Arterial Nitroglycerin Parenchymal Blood Volume (PBV) Imaging, Nitroglycerin, Medical Record Review - Hepatocellular Carcinoma (HCC), Liver Cancer, Adult | Phase 2 | Not yet recruiting | University of California, San Francisco | 50 | 2026-12-15 | 2026-10-13 |
| Testing the Combination of Anti-cancer Drugs Actimab-A and Cemiplimab (REGN2810) to Improve Outcomes for Patients With Recurrent Glioblastoma Actinium Ac 225 Lintuzumab, Biospecimen Collection, Cemiplimab - Recurrent Glioblastoma, IDH-Wildtype, Recurrent Gliosarcoma | Phase 1 | Not yet recruiting | National Cancer Institute (NCI) | 30 | 2026-12-04 | 2026-06-12 |
| Pluvicto for the Treatment of African American Men With Metastatic Castration-Resistant Prostate Cancer Biopsy Procedure, Biospecimen Collection, Bone Scan - Metastatic Castration-Resistant Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8 | Phase 2 | Not yet recruiting | Emory University | 88 | 2026-11-02 | 2026-10-06 |
| A Study of [225Ac]Ac-AKY-2519 in Patients With B7-H3 Expressing Solid Tumors [225Ac]Ac-AKY-2519 (therapeutic), [64Cu]Cu-AKY-2519 (imaging) - NSCLC, NSCLC (Advanced Non-small Cell Lung Cancer) | Phase 1 | Recruiting | Aktis Oncology, Inc. | 152 | 2026-11-01 | 2026-10-22 |
| FH-WT1-E50 TCR T Cells With Azacitidine for the Treatment of Minimal Residual Disease Positive Acute Myeloid Leukemia Autologous HLA-A*02:01-restricted CD4+/CD8+ Anti-WT1 TCR/CD8ab-expressing T-cells, Azacitidine, Biospecimen Collection - Acute Myeloid Leukemia | Phase 1 | Recruiting | Fred Hutchinson Cancer Center | 9 | 2026-10-15 | 2026-09-17 |
| Testing Blinatumomab With or Without Revumenib in Patients With B-cell Acute Lymphoblastic Leukemia With a Genetic Change Requiring More Treatment Biospecimen Collection, Blinatumomab, Bone Marrow Aspiration - Acute Leukemia of Ambiguous Lineage, B Acute Lymphoblastic Leukemia | Phase 2 | Not yet recruiting | SWOG Cancer Research Network | 90 | 2026-10-14 | 2026-10-13 |
| Nirogacestat in Patients With Kaposi Sarcoma Biospecimen Collection, Chest Radiography, Computed Tomography - AIDS-Related Kaposi Sarcoma, Skin Kaposi Sarcoma | Phase 2 | Recruiting | AIDS Malignancy Consortium | 28 | 2026-10-13 | 2026-10-20 |
| Biomarker Validation for Treatment Efficacy and Recurrence Prediction in Hepatocellular Carcinoma No investigational intervention. Participants receive standard clinical care. Clinical data, imaging/pathology information, and available biospecimens are collected for research. - Hepatocellular Carcinoma (HCC) | Recruiting | Tianjin Medical University Cancer Institute and Hospital | 500 | 2026-10-12 | 2026-09-24 | |
| Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial Exercise Intervention, Educational Intervention, Supportive Care - Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage II Breast Cancer AJCC v8 | Not applicable | Recruiting | Wake Forest University Health Sciences | 120 | 2026-10-02 | 2026-10-06 |
Showing 20 of 463. Sign in to see all of them.
Prostatic Neoplasms (27) · Lung Neoplasms (26) · Breast Neoplasms (17) · Carcinoma, Non-Small-Cell Lung (16) · Multiple Myeloma (15) · Leukemia, Myeloid, Acute (13) · Carcinoma, Hepatocellular (12) · Glioma (12) · Sarcoma (12) · Colorectal Neoplasms (10) · Lymphoma, Non-Hodgkin (10) · Osteosarcoma (9) · Wilms Tumor (9) · Myelodysplastic Syndromes (8) · Neoplasm Metastasis (8)
National Cancer Institute (NCI) (59) · Mayo Clinic (33) · M.D. Anderson Cancer Center (15) · Fred Hutchinson Cancer Center (14) · Assiut University (13) · City of Hope Medical Center (12) · University of Washington (11) · Children's Oncology Group (10) · Sohag University (9) · Jonsson Comprehensive Cancer Center (8) · Emory University (7) · Assistance Publique - Hôpitaux de Paris (6) · Thomas Jefferson University (6) · OHSU Knight Cancer Institute (5) · Ohio State University Comprehensive Cancer Center (5)
United States (262) · France (44) · Canada (27) · Puerto Rico (20) · Egypt (16) · Australia (14) · United Kingdom (14) · South Korea (11) · Netherlands (8) · Switzerland (8) · Italy (7) · China (6) · Israel (6) · New Zealand (6) · Turkey (Türkiye) (6)
Ibrahim Aldoss (3) · Michael Schweizer (3) · Timothy A Yap (3) · Armeen Mahvash (2) · Danna Jennings, MD (2) · David S Hong (2) · Elizabeth A Mullen (2) · Hannah Linden (2) · Jeffrey Y Wong (2) · Jeremie Calais, MD (2) · Jia Luo (2) · Jing Zeng (2) · Jordan Gauthier (2)
PMID 31401903, PMID 35175355, PMID 11500705, PMID 11936199, PMID 12642576, PMID 15249451, PMID 15599396, PMID 15960763, PMID 15985467, PMID 16163440, PMID 16463907, PMID 17092218, PMID 17384585, PMID 17459484, PMID 17556308, PMID 17890212, PMID 18581114, PMID 19079345, PMID 19228100, PMID 19383198, PMID 19509223, PMID 19880906, PMID 20055701, PMID 20404381, PMID 20586784, PMID 20623382, PMID 21421848, PMID 21511870, PMID 21765444, PMID 21824941, PMID 21861231, PMID 22098854, PMID 22458247, PMID 22493518, PMID 22759399, PMID 22858800, PMID 22936710, PMID 23114846, PMID 23399938, PMID 23468893, PMID 23793619, PMID 23812905, PMID 23981683, PMID 24004092, PMID 24279296, PMID 24374753, PMID 24432052, PMID 24454900, PMID 24621203, PMID 24788998
U10CA180886 (15), U10CA180820 (11), P30CA033572 (10), U10CA180868 (7), P30CA138292 (6), U10CA180888 (6), UM1CA186709 (6), UM1CA228823 (6), U10CA180821 (5), UM1CA186688 (5), UM1CA186690 (5), P30CA060553 (4), P50CA186781 (3), UM1CA186689 (3), UM1CA186712 (3)